MedTrace Logo

Treatment of the Biceps With Concomitant Supraspinatus Tears

NCT05660031 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-04-25

No results posted yet for this study

Summary

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

Conditions

  • Supraspinatus Tear

Interventions

PROCEDURE

LHB Tenotomy

Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors

PROCEDURE

LHB Tenodesis

"ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.

Sponsors & Collaborators

  • La Tour Hospital

    lead OTHER

Principal Investigators

  • Alexandre Lädermann, MD · La Tour Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • United States
  • Canada
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05660031 on ClinicalTrials.gov